{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T23:06:46Z","timestamp":1772147206538,"version":"3.50.1"},"reference-count":118,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[1997,12,1]],"date-time":"1997-12-01T00:00:00Z","timestamp":880934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunopharmacology"],"published-print":{"date-parts":[[1997,12]]},"DOI":"10.1016\/s0162-3109(97)00057-x","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T18:21:20Z","timestamp":1027621280000},"page":"51-62","source":"Crossref","is-referenced-by-count":126,"title":["Controlling the complement system in inflammation"],"prefix":"10.1016","volume":"38","author":[{"given":"Michael","family":"Kirschfink","sequence":"first","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0162-3109(97)00057-X_BIB1","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.4049\/jimmunol.152.9.4572","article-title":"Isolation of neutralizing anti-C5a monoclonal antibodies from a filamentous phage monovalent Fab display library","volume":"152","author":"Ames","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00006676-199508000-00004","article-title":"Therapeutic regimens in acute experimental pancreatitis in rats: Effects of a protease inhibitor, a beta-agonist, and antibiotics","volume":"11","author":"Araida","year":"1995","journal-title":"Pancreas"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB3","first-page":"223","article-title":"Pharmacological manipulation of complement system","volume":"36","author":"Asghar","year":"1984","journal-title":"Pharm. Rev."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB4","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1097\/00007890-199605150-00004","article-title":"Assessment of hyperacute rejection in a rat-to-primate cardiac xenograft model","volume":"61","author":"Azimzadeh","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB5","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1172\/JCI117520","article-title":"High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments","volume":"94","author":"Basta","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB6","series-title":"Attenuation of acute complement-dependent immune damage in a guinea pig model","first-page":"1974","article-title":"Mechanism of therapeutic effect of high-dose intravenous immunoglobulin","volume":"84","author":"Basta","year":"1989"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB7","first-page":"677","article-title":"Long-term prophylaxis with Cl-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency","volume":"63","author":"Bork","year":"1988","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/01.CIR.91.2.393","article-title":"Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion","volume":"91","author":"Buerke","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB9","first-page":"759","article-title":"Development and analysis of transgenic pigs expressing the human complement regulatory protein CD59 and DAF","volume":"28","author":"Byrne","year":"1996"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00007890-199701150-00027","article-title":"Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage","volume":"63","author":"Byrne","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB11","series-title":"Proteinase Inhibitors","first-page":"403","article-title":"Serpins: The superfamily of plasma serine protease inhibitors","author":"Carrell","year":"1986"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0952-7915(97)80160-4","article-title":"Complement and the immune response","volume":"9","author":"Carroll","year":"1997","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB13","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/00007890-199504150-00023","article-title":"Regulation of the complement cascade by soluble complement receptor type 1. Protective effect in experimental liver ischemia and reperfusion","volume":"59","author":"Chavez Cartaya","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000467892","article-title":"Anaphylatoxin formation in extracorporeal circuits","volume":"3","author":"Chenoweth","year":"1986","journal-title":"Complement"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB15","first-page":"96","article-title":"Complement activation as index of hemodialysis membrane biocompatibility: The choice of methods and assays","volume":"9","author":"Cheung","year":"1994","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB16","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1681\/ASN.V281328","article-title":"Modulation of complement activation on hemodialysis membranes by immobilized heparin","volume":"2","author":"Cheung","year":"1992","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB17","series-title":"Comparative effects of systemically administered cobra venom factor and soluble complement receptor type 1 in a guinea pig-to-rat model","first-page":"650","article-title":"Prolongation of discordant renal xenograft survival by depletion of complement","volume":"7","author":"Chrupcala","year":"1994"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4049\/jimmunol.105.1.55","article-title":"Depletion of plasma complement in vivo by a protein of cobra venom: Its effect on various immunologic reactions","volume":"105","author":"Cochrane","year":"1970","journal-title":"J. Immunol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF00205873","article-title":"Methods to detect and quantitate complement activation","volume":"6","author":"Cooper","year":"1983","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB20","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1681\/ASN.V5111888","article-title":"The effects of soluble recombinant complement receptor 1 on complement-mediated experimental glomerulonephritis","volume":"5","author":"Couser","year":"1995","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB21","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/nm0995-964","article-title":"The generation of transgenic pigs as potential organ donors for humans","volume":"1","author":"Cozzi","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0142-9612(87)90111-6","article-title":"Molecular weight dependency of the acquired anti-complementary and anticoagulant activities of specifically substituted dextrans","volume":"8","author":"Crepon","year":"1987","journal-title":"Biomaterials"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/10408368609110272","article-title":"Complement in the pathophysiology and diagnosis of human diseases","volume":"24","author":"Dalmasso","year":"1986","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0162-3109(92)90020-D","article-title":"The complement system in xenotransplantation","volume":"24","author":"Dalmasso","year":"1992","journal-title":"Immunopharmacology"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB25","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/00007890-199109000-00029","article-title":"Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor","volume":"52","author":"Dalmasso","year":"1991","journal-title":"Transplantation"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB26","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/00005373-198706000-00005","article-title":"Complement depletion in a porcine model of septic acute respiratory disease","volume":"27","author":"Dehring","year":"1987","journal-title":"J. Trauma"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0887-7963(91)70199-5","article-title":"The regulation of complement on cell surfaces","volume":"V","author":"Devine","year":"1991","journal-title":"Transfusion Med. Rev."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB28","series-title":"Complement Today","first-page":"96","article-title":"Heparin is not just an anticoagulant anymore: Six and one-half decades of studies on the ability of heparin to regulate complement activity","author":"Edens","year":"1993"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB29","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0161-5890(95)00099-2","article-title":"In vitro and in vivo inhibition of complement activity by a single chain Fv fragment recognizing human C5","volume":"32","author":"Evans","year":"1995","journal-title":"Mol. Immunol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB30","first-page":"5867","article-title":"Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membranes","volume":"76","author":"Fearon","year":"1979"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2249.1991.tb06206.x","article-title":"Anti-inflammmatory and immunosuppressive effects of recombinant soluble complement receptors","volume":"86","author":"Fearon","year":"1991","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB32","first-page":"12775","article-title":"Molecular cloning and derived primary structure of cobra venom factor","volume":"91","author":"Fritzinger","year":"1994"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB33","first-page":"393","article-title":"Inhibitory effect of FUT-175 on complement activation and its application for glomerulonephritis with hypocomplementemia","volume":"35","author":"Fujita","year":"1993","journal-title":"Nippon Jinzo Gakkai Shi"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB34","series-title":"Successful treatment of acute episodes of angioedema with partly purified C1 inhibitor","first-page":"542","article-title":"Replacement therapy in hereditary angioedema","volume":"302","author":"Gadek","year":"1980"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB35","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000157026","article-title":"Complement activation in extracorporeal circulation: Physiological and pathological implications","volume":"5","author":"Gardinali","year":"1986","journal-title":"Pathol. Immunopathol. Res."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB36","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1097\/00007890-196709000-00008","article-title":"Effect of cobra venom-factor induced inhibition of complement activity on allograft and xenograft rejection reactions","volume":"5","author":"Gewurz","year":"1967","journal-title":"Transplantation"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB37","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0003-4975(93)90264-I","article-title":"Complement inhibition with soluble complement receptor type 1 in cardiopulmonary bypass","volume":"55","author":"Gillinov","year":"1993","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00002281-199401000-00003","article-title":"New developments in the treatment of systemic vasculitis","volume":"6","author":"Gross","year":"1994","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB39","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1172\/JCI116516","article-title":"Endotoxin-induced pulmonary dysfunction is prevented by C1-esterase inhibitor","volume":"91","author":"Guerrero","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF01738946","article-title":"Cl-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2","volume":"19","author":"Hack","year":"1993","journal-title":"Intensive Care Med."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB41","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/clin.1993.1079","article-title":"Leukocyte adhesion deficiency syndrome: Insights into the molecular basis of leukocyte emigration","volume":"67","author":"Harlan","year":"1993","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0022-1759(93)90326-3","article-title":"Rapid quantification of C3a and C5a using a combination of chromatographic and immunoassay procedure","volume":"166","author":"Hartmann","year":"1993","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB43","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00024382-199703001-00297","article-title":"Analysis of complement proteins in polytrauma patients-correlation with injury severity, sepsis, and outcome","volume":"7","author":"Hecke","year":"1997","journal-title":"Shock"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB44","first-page":"1","article-title":"Protection of porcine endothelial cells from complement-mediated cytotoxicity by the human complement regulators CD59, C1 inhibitor and soluble complement receptor 1: Analysis in a pig-to-human in vitro model relevant to hyperacute rejection","volume":"62","author":"Heckl-\u00d6streicher","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB45","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.4049\/jimmunol.149.5.1723","article-title":"Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat","volume":"149","author":"Hill","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev.pa.34.040194.000313","article-title":"Complement activation and inhibition in myocardial ischemia and reperfusion injury","volume":"34","author":"Homeister","year":"1994","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB47","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/eji.1830260522","article-title":"Inhibition of interleukin-6 synthesis in an animal model of septic shock by anti-C5a monoclonal antibodies","volume":"26","author":"H\u00f6pken","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB48","first-page":"309","article-title":"The role of the complement system in shock and tissue injury induced by tumor necrosis factor and endotoxin","volume":"70","author":"Hsueh","year":"1990","journal-title":"Immunology"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB49","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000467889","article-title":"Biochemistry and biology of anaphylatoxins","volume":"3","author":"Hugli","year":"1986","journal-title":"Complement"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB50","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/eji.1830230321","article-title":"Treatment with anti-CR3 antibodies ED7 and ED8 suppresses experimental allergic encephalomyelitis in Lewis rats","volume":"23","author":"Huitinga","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0165-2478(91)90243-4","article-title":"FUT-175 as a potent inhibitor of C5\/C3 convertase activity for production of C5a and C3a","volume":"27","author":"Inagi","year":"1991","journal-title":"Immunol. Lett."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB52","first-page":"801","article-title":"Complement activates Kuffer cells and neutrophils during reperfusion after hepatic ischemia","volume":"264","author":"Jaeschke","year":"1993","journal-title":"Am. J. Physiol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB53","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000463181","article-title":"Biomedical polymers differ in their capacity to activate complement","volume":"8","author":"Janatova","year":"1991","journal-title":"Complement Inflamm."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB54","first-page":"36","article-title":"Complement activation during extracorporeal therapy: Biochemistry, cell biology and clinical relevance","volume":"9","author":"Johnson","year":"1994","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB55","first-page":"171","article-title":"Mapping of the C3b-binding site of CR1 and construction of a chimeric complement inhibitor","volume":"8","author":"Kalli","year":"1991","journal-title":"Complement Inflamm."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB56","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.2460\/ajvr.1990.51.11.1826","article-title":"Molecular definition of the bovine granulocythopathy syndrome: Identification of deficiency of the Mac-1 (CD11b\/CD18) glycoprotein","volume":"51","author":"Kehrli","year":"1990","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB57","first-page":"1011","article-title":"Monoclonal antibodies to complement C3 prolong survival of discordant xenografts: guinea pig heart to rat transplantation","volume":"26","author":"Kemp","year":"1994"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB58","series-title":"The Complement System","article-title":"The clinical laboratory: Testing the complement system","author":"Kirschfink","year":"1997"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB59","first-page":"221","article-title":"Extracorporeal circulation: In vivo and in vitro analysis of complement activation by heparin-bonded surfaces","volume":"40","author":"Kirschfink","year":"1993","journal-title":"Circ. Shock"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB60","first-page":"2556","article-title":"Complement activation in renal allograft recipients","volume":"24","author":"Kirschfink","year":"1992"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB61","first-page":"149","article-title":"Antagonistic peptides against human anaphylatoxin C5a","volume":"86","author":"Kaneko","year":"1995","journal-title":"Immunology"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB62","first-page":"604","article-title":"In vitro and in vivo investigation of anticomplement agents FUT-175 and K76COOH, in the prevention of hyperacute rejection following discordant xenotransplantation in a nonhuman primate model","volume":"28","author":"Kobayashi","year":"1996"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB63","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/1380-2933(96)00425-3","article-title":"Epitope mapping of a C5a neutralizing mAb using a combined approach of phage display, synthetic peptides and side-directed mutagenesis","volume":"2","author":"Kola","year":"1996","journal-title":"Immunotechnology"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB64","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1126\/science.7541557","article-title":"In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium","volume":"269","author":"Kooyman","year":"1995","journal-title":"Science"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB65","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/00007890-199605270-00018","article-title":"Expression of human CD59 in transgenic pig organs enhances organ survival in an ex vivo xenogeneic perfusion model","volume":"61","author":"Kroshus","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB66","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/00007890-199512000-00003","article-title":"Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation","volume":"60","author":"Kroshus","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB67","first-page":"1400","article-title":"Production of pigs transgenic for human decay accelerating factor","volume":"26","author":"Langford","year":"1994"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB68","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1021\/jm00080a008","article-title":"Substituted 4,6-diaminoquinolines as inhibitors of C5a receptor binding","volume":"35","author":"Lanza","year":"1992","journal-title":"J. Med. Chem."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB69","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1182\/blood.V88.1.184.184","article-title":"High doses of immunoglobulin G attenuate immune aggregate-mediated complement activation by enhancing physiologic cleavage of C3b in C3bn-IgG complexes","volume":"88","author":"Lutz","year":"1996","journal-title":"Blood"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB70","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1172\/JCI118297","article-title":"Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation","volume":"96","author":"Magee","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB71","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1365-2249.1994.tb06112.x","article-title":"Effects of decomplementation with cobra venom factor on experimental vasculitis","volume":"97","author":"Mathieson","year":"1994","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB72","doi-asserted-by":"crossref","first-page":"749","DOI":"10.4049\/jimmunol.156.2.749","article-title":"Regulation of complement activity by immunoglobulin. I. Effect of immunoglobulin isotype on C4 uptake on antibody-sensitized sheep erythrocytes and solid phase immune complexes","volume":"156","author":"Miletic","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB73","article-title":"Attenuation of changes in leukocyte surface markers and complement activation with heparincoated cardiopulmonary bypass","author":"Moen","year":"1997","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB74","first-page":"24","article-title":"Biocompatibility: Complement as a mediator of tissue damage and an indicator of incompatibility","volume":"14","author":"Mollnes","year":"1997","journal-title":"Clin. Exp. Immunogenet."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB75","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1525-1594.1995.tb02450.x","article-title":"A new model for evaluation of biocompatibility: Combined determination of neoepitopes in blood and on artificial surfaces demonstrates reduced complement activation by immobilization of heparin","volume":"19","author":"Mollnes","year":"1995","journal-title":"Artif. Organs."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB76","series-title":"Clinical Aspects and Relevance to Disease","article-title":"Complement","author":"Morgan","year":"1990"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB77","series-title":"Characterization of neutralizing antibodies specific for a peptide, C5aR-(9\u201329), derived from the predicted aminoterminal sequence of the human C5a receptor","first-page":"377","article-title":"Anti-C5a receptor antibodies","volume":"151","author":"Morgan","year":"1993"},{"issue":"Suppl. 1","key":"10.1016\/S0162-3109(97)00057-X_BIB78","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/cei.1996.104.s1.3","article-title":"Mechanisms of action of intravenous immune globulin in immune-mediated diseases","volume":"104","author":"Mouthon","year":"1996","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB79","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.bi.57.070188.001541","article-title":"Molecular organization and function of the complement system","volume":"57","author":"M\u00fcller-Eberhard","year":"1988","journal-title":"Ann. Rev. Biochem."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB80","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.4049\/jimmunol.150.6.2401","article-title":"Role of leukocyte adhesion molecules in complement-induced injury","volume":"150","author":"Mulligan","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB81","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.4049\/jimmunol.150.6.2407","article-title":"Role of \u03b21 and \u03b22 integrins and ICAM-1 in lung injury following deposition of IgG and IgA immune complexes","volume":"150","author":"Mulligan","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB82","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.4049\/jimmunol.158.4.1857","article-title":"C5a-dependent up-regulation in vivo of lung vascular P-selectin","volume":"158","author":"Mulligan","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB83","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM198608073150601","article-title":"The treatment of Kawasaki syndrome with intravenous gamma globulin","volume":"315","author":"Newburger","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB84","first-page":"8","article-title":"Capillary leak syndrome following bone marrow transplantation","volume":"9","author":"N\u00fcmberger","year":"1996","journal-title":"Biomed. Progr."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB85","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1182\/blood.V72.6.1841.1841","article-title":"Quantification of plasma factor XIIa-Cl-inhibitor and kallikrein-Cl-inhibitor complexes in sepsis","volume":"72","author":"Nuijens","year":"1988","journal-title":"Blood"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB86","series-title":"Identification of a potential ligand binding site on the NH2-terminal domain","first-page":"3785","article-title":"Probing the human receptor for C5a anaphylatoxin with site-directed antibodies","volume":"151","author":"Oppermann","year":"1993"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB87","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.4049\/jimmunol.152.11.5477","article-title":"Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis","volume":"152","author":"Piddlesden","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB88","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/00007890-199112000-00001","article-title":"The barrier to xenotransplantation","volume":"52","author":"Platt","year":"1991","journal-title":"Transplantation"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB89","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0022-4804(91)90202-W","article-title":"The effect of soluble complement receptor type 1 on hyperacute allograft rejection","volume":"50","author":"Pmitt","year":"1991","journal-title":"J. Surg. Res."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB90","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.4049\/jimmunol.149.5.1744","article-title":"Role of complement in endotoxin\/platelet-activating factor-induced lung injury","volume":"149","author":"Rabenovici","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB91","series-title":"8th European Congress of Intensive Care Medicine","first-page":"761","article-title":"The protective effect of Cl-inhibitor on thermal trauma: First results from an animal study","author":"Radke","year":"1995"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB92","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/0003-4975(93)90882-I","article-title":"Heparin-coated bypass circuits reduce pulmonary injury","volume":"56","author":"Redmond","year":"1993","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB93","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0192-0561(94)90050-7","article-title":"Protective effect of cobra venom factor on pulmonary injury induced by oleic acid","volume":"16","author":"Ren","year":"1994","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB94","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/00007890-199512000-00017","article-title":"Monoclonal antibodies directed against human C5 and C8 block complement-mediated damage of xenogeneic cells and organs","volume":"60","author":"Rollins","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB95","first-page":"36","article-title":"A humanized anti-C5 scFv blocks platelet and leukocyte activation and exhibits prolonged pharmacokinetics and pharmacodynamics in humans","volume":"14","author":"Rollins","year":"1997","journal-title":"Exp. Clin. Immunogenet."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB96","series-title":"The Complement System","author":"Rother","year":"1988"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB97","article-title":"Hereditary and acquired complement deficiencies in animals and man","volume":"vol. 39","author":"Rother","year":"1986"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB98","first-page":"675","article-title":"Reduction in cellular and vascular rejection by blocking leukocyte adhesion molecule receptors","volume":"142","author":"Sadahiro","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB99","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000467851","article-title":"Biochemistry and pathophysiology of human CI inhibitor: Current issues","volume":"2","author":"Schapira","year":"1985","journal-title":"Complement"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB100","first-page":"768","article-title":"Human decay accelerating factor successfully protects pig hearts from hyperacute rejection by human blood","volume":"28","author":"Schmoeckel","year":"1996"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB101","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1172\/JCI113364","article-title":"Reduction of experimental canine reperfusion injury by a monoclonal antibody (anti-Mol, anti-CDllb) that inhibits leukocyte adhesion","volume":"81","author":"Simpson","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB102","series-title":"A role for C5a","first-page":"489","article-title":"Endotoxin-induced shock in the rat","volume":"135","author":"Smedegard","year":"1989"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB103","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1172\/JCI112506","article-title":"Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates","volume":"77","author":"Stevens","year":"1986","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB104","first-page":"13","article-title":"Capillary leak syndrome after open heart surgery for congenital heart defects: Therapy with Cl-inhibitor","volume":"9","author":"Stieh","year":"1996","journal-title":"Biomed. Progr."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB105","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7326\/0003-4819-107-2-367","article-title":"Intravenous immunoglobulins as therapeutic agents (clinical conference)","volume":"107","author":"Stiehm","year":"1987","journal-title":"Ann. Int. Med."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB106","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1128\/CDLI.3.2.175-183.1996","article-title":"Circulating complement proteins in patients with sepsis or systemic inflammatory response syndrome","volume":"3","author":"St\u00f6ve","year":"1996","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB107","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/00007890-199701270-00022","article-title":"Morphology of hDAF (CD55) transgenic pig kidneys following ex-vivo hemoperfusion with human blood","volume":"63","author":"Storck","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB108","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/0142-9612(95)93581-W","article-title":"Effect of substituted dextran derivative on complement activation in vivo","volume":"16","author":"Thomas","year":"1995","journal-title":"Biomaterials"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB109","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0161-5890(96)00028-4","article-title":"Sulfonated dextran inhibits complement activation and complement-dependent cytotoxicity in an in vitro model of hyperacute xenograft rejection","volume":"33","author":"Thomas","year":"1996","journal-title":"Mol. Immunol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB110","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0167-5699(96)80908-X","article-title":"Mannose-binding lectin: The pluripotent molecule of the innate immune system","volume":"17","author":"Turner","year":"1996","journal-title":"Immunol. Today"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB111","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0165-5728(95)00006-N","article-title":"Complement depletion affects demyelination and inflammation in experimental allergic neuritis","volume":"58","author":"Vriesendorp","year":"1995","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB112","first-page":"8563","article-title":"Amelioration of lupus-like autoimmune disease in NZB\/WFI mice after treatment with a blocking monoclonal antibody specific for complement component C5","volume":"93","author":"Wang","year":"1996"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB113","first-page":"8955","article-title":"Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease","volume":"92","author":"Wang","year":"1995"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB114","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1126\/science.2371562","article-title":"Soluble human complement receptor type 1: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis","volume":"249","author":"Weisman","year":"1990","journal-title":"Science"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB115","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1159\/000463204","article-title":"Inhibition of terminal complement complex formation and cell lysis by monoclonal antibodies","volume":"8","author":"W\u00fcrzner","year":"1991","journal-title":"Complement Inflamm."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB116","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1227\/00006123-199203000-00008","article-title":"Therapeutic trial of cerebral vasospasm with the serine protease inhibitor, FUT-175, administered in the acute stage after subarachnoid hemorrhage","volume":"30","author":"Yanamoto","year":"1992","journal-title":"Neurosurgery"},{"key":"10.1016\/S0162-3109(97)00057-X_BIB117","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4049\/jimmunol.146.1.250","article-title":"Recombinant soluble human complement receptor type 1 inhibits inflammation in the reversed passive Arthus reaction in rats","volume":"146","author":"Yeh","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/S0162-3109(97)00057-X_BIB118","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2249.1990.tb05171.x","article-title":"Complement activation and the prognostic value of C3a in patients at risk of the adult respiratory distress syndrome","volume":"79","author":"Zilow","year":"1990","journal-title":"Clin. Exp. Immunol."}],"container-title":["Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016231099700057X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016231099700057X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T22:11:27Z","timestamp":1733350287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016231099700057X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,12]]},"references-count":118,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[1997,12]]}},"alternative-id":["S016231099700057X"],"URL":"https:\/\/doi.org\/10.1016\/s0162-3109(97)00057-x","relation":{},"ISSN":["0162-3109"],"issn-type":[{"value":"0162-3109","type":"print"}],"subject":[],"published":{"date-parts":[[1997,12]]}}}